Evidence map›Paper›PMID 7532858›Full record

ArticleNucleic acids research1995

Antisense 2'-O-alkyl oligoribonucleotides are efficient inhibitors of reverse transcription.

C Boiziau, B Larrouy, B S Sproat, J J Toulmé

Open access · greenAbstract read
In one paragraph

Article in Nucleic acids research, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. Dietary zinc supplementation inhibits bacterial plasmid conjugationApplied and environmental microbiology · 2024
    Article
  2. Review
  3. Review
  4. Article
  5. S-adenosylmethionine directly inhibits binding of 30S ribosomal subunits to the SMK box translational riboswitch RNA.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

C BoiziauLaboratoire de Biophysique Moléculaire, INSERM U 386, Université Bordeaux II, France.
B Larrouy
B S Sproat
J J Toulmé
Université de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reverse transcription is one step of the retroviral development which can be inhibited by antisense oligonucleotides complementary to the RNA template. 2'-O-Alkyl oligoribonucleotides are of interest due to their nuclease resistance, and to the high stability of the hybrids they form with RNA. Oligonucleotides, either fully or partly modified with 2'-O-alkyl residues, were targeted to an RNA template to prevent cDNA synthesis by the Avian Myeloblastosis Virus reverse transcriptase (AMV RT). Fully-modified 2'-O-allyl 17mers were able to specifically block reverse transcription via an RNase H-independent mechanism, with efficiencies comparable to those observed with phosphodiester (PO) and phosphorothioate oligonucleotides. Sandwich 2'-O-alkyl/PO/2'-O-alkyl oligonucleotides, supposed to combine the properties of 2'-O-alkyl modifications (physical blocking of the RT) to those of the PO window (RNase H-mediated cleavage of the RNA) were quasi-stoichiometric inhibitors when adjacent to the primer, but remained without any effect when non-adjacent. They were not able to compete with the polymerase and inhibited reverse transcription only through RNase H-mediated cleavage of the target.

Indexed as

Avian Myeloblastosis VirusBase SequenceDNA, ComplementaryDNA PrimersGlobinsMolecular Sequence DataMolecular StructureOligonucleotides, AntisenseReverse Transcriptase InhibitorsRibonuclease HRNA-Directed DNA PolymeraseRNA, MessengerSubstrate SpecificityTranscription, GeneticDNA, ComplementaryDNA PrimersGlobinsOligonucleotides, AntisenseReverse Transcriptase InhibitorsRibonuclease HRNA-Directed DNA PolymeraseRNA, Messenger

Identifiers

PMID7532858
PMCPMC306631
OpenAlexW2042342849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.